An anti-inflammatory role for Vα14 NK T cells in Mycobacterium bovis bacillus Calmette-Guérin-infected mice

Journal of Immunology

Volumn 171, Issue 4, 2003, Pages 1961-1968

  Dieli, Francesco ^a   Taniguchi, Masaru ^b   Kronenberg, Mitchell ^c   Sidobre, Stephane ^c   Ivanyi, Juraj ^d   Fattorini, Lanfranco ^e   Iona, Elisabetta ^e   Orefici, Graziella ^e   De Leo, Giacomo ^a   Russo, Domenica ^f   Caccamo, Nadia ^a   Sireci, Guido ^a   Di Sano, Caterina ^f   Salerno, Alfredo ^a,f  

^a UNIVERSITY OF PALERMO   (Italy)

^b CHIBA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c LA JOLLA INSTITUTE FOR ALLERGY AND IMMUNOLOGY   (United States)

^d KING'S COLLEGE LONDON   (United Kingdom)

^e ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^f CNR   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BCG VACCINE; MESSENGER RNA; MONOCLONAL ANTIBODY; NEUTRALIZING ANTIBODY; TUMOR NECROSIS FACTOR ANTIBODY;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CELL ACTIVITY; CELL INFILTRATION; CELL POPULATION; CELL TYPE; CONTROLLED STUDY; CYTOKINE PRODUCTION; HISTOPATHOLOGY; IMMUNOPATHOLOGY; IN VIVO STUDY; LIVER GRANULOMA; LUNG GRANULOMA; LYMPHOCYTE MIGRATION; MACROPHAGE; MOUSE; MYCOBACTERIOSIS; MYCOBACTERIUM BOVIS; MYCOBACTERIUM TUBERCULOSIS; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SPLEEN; T LYMPHOCYTE; V ALPHA NATURAL KILLER CELL;

EID: 0042134878     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.171.4.1961     Document Type: Article

References (47)

1. Flynn, J. L., and J. Chan. 2001. Immunology of tuberculosis. Annu. Rev. Immunol. 19:93.
2. Cooper, A. M., D. K. Dalton, T. A. Stewart, J. P. Griffin, D. G. Russell, and I. M. Orme. 1993. Disseminated tuberculosis in interferon γ gene-disrupted mice. J. Exp. Med. 178:2243.
3. Flynn, J. L., J. Chan, K. J. Triebold, D. K. Dalton, T. A. Stewart, and B. R. Bloom. 1993. An essential role for interferon γ in resistance to Mycobacterium tuberculosis infection. J. Exp. Med. 178:2249.
4. Jouanguy, E., F. Altare, S. Lamhamedi, P. Revy, J. F. Emile, M. Newport, M. Levin, S. Blanche, E. Seboun, A. Fischer, et al. 1996. Interferon-γ-receptor deficiency in an infant with fatal bacille Calmette-Guérin infection. N. Engl. J. Med. 335:1956.
5. Ladel, C. H., J. Hess, S. Daugelat, P. Mombaerts, S. Tonegawa, and S. H. R. Kaufmann. 1995. Contribution of αβ and γδ T lymphocytes to immunity against Mycobacterium bovis bacillus Calmette Guérin: studies with T cell receptor-deficient mutant mice. Eur. J. Immunol. 25:838.
6. + cells: new clues to their origin, specificity and function. J. Exp. Med. 181:633.
7. Kronenberg, M., and L. Gapin. 2002. The unconventional lifestyle of NKT cells. Nat. Rev. Immunol. 2:557.
8. - T cells in mice and humans. J. Exp. Med. 180:1097.
9. + T cells upon NKR-P1 cross-linking. J. Exp. Med. 183:2391.
10. + T cells in IL-12-induced immune responses in vivo. J. Immunol. 160:16.
11. Burdin, N., L. Brossay, and M. Kronenberg. 1999. Immunization with α-galactosylceramide polarizes CD1-reactive NK T cells toward Th2 cytokine synthesis. Eur. J. Immunol. 29:2014.
12. + natural killer T cells by Mycobacterium bovis bacillus Calmette Guérin. Eur. J. Immunol. 29:650.
13. Apostolou, I., Y. Takahama, C. Belmant, T. Kawano, M. Huerre, G. Marchal, J. Cui, M. Taniguchi, H. Nakauchi, J. J. Fourniè, et al. 1999. Murine natural killer cells contribute to the granulomatous reaction caused by mycobacterial cell walls. Proc. Natl. Acad. Sci. USA 96:5141.
14. Mempel, M., C. Ronet, F. Suarez, M. Gilleron, G. Puzo, L. Van Kaer, A. Lehuen, P. Kourilsky, and G. Gachelin. 2002. Natural killer T cells restricted by the monomorphic MHC class 1b CD1d molecules behave like inflammatory cells. J. Immunol. 168:365.
15. Behar, S. M., C. C. Dascher, M. J. Grusby, C. R. Wang, and M. B. Brenner. 1999. Susceptibility of mice deficient in CD1D or TAP1 to infection with Mycobacterium tuberculosis. J. Exp. Med. 189:1973.
16. 2-microglobulin-restricted mechanism influencing early lymphocyte accumulation and subsequent resistance to tuberculosis in the lung. Am. J. Respir. Cell Mol. Biol. 23:188.
17. Kawakami, K., Y. Kinjo, K. Uezu, S. Yara, K. Miyagi, Y. Koguchi, T. Nakayama, M. Taniguchi, and A. Saito. 2002. Minimal contribution of Vα14 natural killer T cells to Th1 response and host resistance against mycobacterial infection in mice. Microbiol. Immunol. 46:207.
18. Sugawara, I., H. Yamada, S. Mizuno, C. Li, T. Nakayama, and M. Taniguchi. 2002. Mycobacterial infection in natural killer T cell knockout mice. Tuberculosis 82:97.
19. Szalay, G., U. Zugel, C. H. Ladel, and S. H. E. Kaufmann. 1999. Participation of group 2 CD1 molecules in the control of murine tuberculosis. Microbes Infect. 14:1153.
20. Chackerian, A., J. Alt, V. Perera, and S. M. Behar. 2002. Activation of NKT cells protects mice from tuberculosis. Infect. Immun. 70:6302.
21. Cui, J., T. Shin, T. Kawano, H. Sato, E. Kondo, I. Toura, Y. Kaneko, H. Koseki, M. Kanno, and M. Taniguchi. 1997. Requirement for Vα14 NKT cells in IL-12-mediated rejection of tumors. Science 278:1623.
22. Dieli, F., G. Sireci, D. Russo. M. Taniguchi, J. Ivanyi, C. Fernandez, M. Troye-Blomberg, G. De Leo, and A. Salerno. 2000. Resistance of natural killer T cell-deficient mice to systemic Shwartzman reaction. J. Exp. Med. 192:1645.
23. Dieli, F., J. Ivanyi, P. Marsh, A. Williams, I. Naylor, G. Sireci, N. Caccamo, C. Di Sano, and A. Salerno. 2003. Characterization of lung γδ T cells following intranasal infection with Mycobacterium bovis bacillus Calmette-Guérin. J. Immunol. 170:463.
24. Matsuda, J. L., O. V. Naidenko, L. Gapin, T. Nakayama, M. Taniguchi, R. Wang, Y. Koezuka, and M. Kronenberg. 2000. Tracking the response of natural killer T cells to a glycolipid antigen using CD1d tetramers. J. Exp. Med. 192:741.
25. - T cells with a skewed variable region repertoire after infection with Listeria monocytogenes. Eur. J. Immunol. 25:1985.
26. + Vα14 NKT cells play a crucial role in an early stage of protective immunity against infection with Leishmania major, Int. Immunol. 12:1267.
27. + TCRαβ intermediate cells increase during experimental malaria infection and are able to exhibit inhibitory activity against the parasite liver stage in vitro. J. Immunol. 164:1463.
28. Kawakami, K., Y. Kinio, K. Uezu, S. Yara, K. Miyagi, Y. Koguchi, T. Nakayama, M. Taniguchi, and A. Saito. 2001. Monocyte chemoattractant protein-1-dependent increase of Vα14 NKT cells in lungs and their roles in Th1 response and host defense in cryptococcal infection. J. Immunol. 167:6525.
29. Nakano, Y., H. Hisaeda, T. Sakai, H. Ishiwaka, M. Zhang, Y. Maekawa, T. Zhang, M. Takashima, M. Nishitami, R. A. Good, et al. 2002. Roles of NKT cells in resistance against infection with Toxoplasma gondii and expression of heat shock protein 65 in host macrophages. Microbes Infect. 4:1.
30. Guinet, F., C. Ronet, M. Mempel, M. Huerre, E. Carniel, and G. Gachelin. NKT cells-containing inflammatory lesions induced by Yersinia paratuberculosis glycolipids. Immunol. Lett. 80:113.
31. Liu, C. C., B. Perussia, and J. D. E. Young. 2000, The emerging role of IL-15 in NK cell development. Immunol. Today 21:113.
32. Faunce, D. E., K. Sonoda, and J. Stein-Streilein. 2001. MIP-2 recruits NKT cells to the spleen during tolerance induction. J. Immunol. 166:313.
33. Moretta, A. 2002. Natural killer cells and dendritic cells: rendezvous in abused tissues. Nat. Rev. Immunol. 2:957.
34. + NKT cell subsets with distinct cytokine-producing capacity. Blood 100:11.
35. Hameg, A., I. Apostolou, M. Leite-de-Moraes, J. M. Gombert, C. Garcia, Y. Koezuka, J. F. Bach, and A. Herbelin. 2000. A subset of NKT cells that lacks NK1.1 marker, expresses CD1d molecules and autopresents the α-galactosylceramide antigen. J. Immunol. 165:4917.
36. Benlagha, K., T. Kyin, A. Beavis, L. Teyton, and A. Bendelac. 2002. A thymic precursor of the NKT cell lineage. Science 296:553.
37. Flynn, J. L., M. M. Goldstein, J. Chan, K. J. Triebold, K. Pfeffer, C. J. Lowenstein, R. Schreiber, T. W. Mak, and B. R. Bloom. 1995. Tumor necrosis factor-α is required in the protective immune response against Mycobacterium tuberculosis in mice. Immunity 2:561.
38. Kindler, V., A. P. Sappino, G. E. Grau, P. F. Pignet, and P. Vassalli. 1989. The inducing role of tumour necrosis factor in the development of bactericidal granulomas during BCG infection. Cell 56:731.
39. Ming, W. J., L. Bersani, and A. Mantovani. 1987. Tumor necrosis factor is chemotactic for monocyte and polymorphonuclear leukocytes. J. Immunol. 138:1469.
40. Josien, R., B. R. Wong, H. L. Li, R. M. Steinman, and Y. Choi. 1999. TRANCE, a TNF family member, is differentially expressed on T cell subsets and induces cytokine production in dendritic cells. J. Immunol. 162:2562.
41. Bekker, L. G., A. L. Moreira, A. Bergtold, S. Freeman, B. Ryffel, and G. Kaplan. 2000. Immunopathologic effects of tumor necrosis factor a in murine mycobacterial infection are dose dependent. Infect. Immun. 68:6954.
42. Godfrey, D. J., K. J. Hammond, L. D. Poulton, M. J. Smyth, and A. G. Naxter. 2000. NKT cells: facts, functions and fallacies. Immunol. Today 21:573.
43. Sonoda, K., M. Exley, S. Snapper, S. P. Balk, and J. Stein-Streilein. 1999. CD1-reactive natural killer T cells are required for development of systemic tolerance through an immune-privileged site. J. Exp. Med. 190:1215.
44. Moodycliffe, A. M., D. Nghiem, C. Clydesdale, and S. E. Ullrich. 2000. Immune suppression and skin cancer development: regulation by NKT cells. Nat. Immunol. 1:521.
45. Sharif, S., G. A. Arreaza, P. Zucker, Q. S. Mi, J. Sondhi, O. V. Naidenko, M. Kronenberg, Y. Koezuka, T. Delovitch. J. M. Gombert, et al. 2001. Activation of natural killer T cells by α-galactosylceramide treatment prevents the onset and recurrence of autoimmune type 1 diabetes. Nat. Med. 7:1057.
46. Hong, S., M. T. Wilson, I. Serizawa, L. Wu, N. Singh. O. V. Naidenko, T. Miura, T. Haba, D. C. Scherer, J. Wei, et al. 2001. The natural killer T-cell ligand α-galactosylceramide prevents autoimmune diabetes in non-obese diabetic mice. Nat. Med. 7:1052.
47. Singh, A. K., M. T. Wilson, S. Hong, D. Olivares-Villagomez, C. Du, A. K. Stanic, S. Joyce, S. Sriram, Y. Koezuka, and L. Van Kaer. 2001. Natural killer T cell activation protects mice against autoimmune experimental encephalomyelitis. J. Exp. Med. 194:1801.